Show simple item record

Inclusion criteria as widely used for rheumatoid arthritis clinical trials: Patient eligibility in a Turkish cohort

dc.contributor.authorGogus, F
dc.contributor.authorYazici, H
dc.contributor.authorYazici, Y
dc.date.accessioned2021-03-03T21:13:27Z
dc.date.available2021-03-03T21:13:27Z
dc.date.issued2005
dc.identifier.citationGogus F., Yazici Y., Yazici H., "Inclusion criteria as widely used for rheumatoid arthritis clinical trials: Patient eligibility in a Turkish cohort", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.23, sa.5, ss.681-684, 2005
dc.identifier.issn0392-856X
dc.identifier.othervv_1032021
dc.identifier.otherav_5e06b4e3-6fb6-4ec6-97fa-f183f8773c8a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/65772
dc.description.abstractObjective. To identify, the proportion of patients fulfilling the inclusion criteria widely used in most clinical trials for rheumatoid arthritis (RA) - including the recent clinical trials of anti-Tinnor Necrosis Factor a (TNF alpha) agents - in a Turkish cohort.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleInclusion criteria as widely used for rheumatoid arthritis clinical trials: Patient eligibility in a Turkish cohort
dc.typeMakale
dc.relation.journalCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.contributor.department, ,
dc.identifier.volume23
dc.identifier.issue5
dc.identifier.startpage681
dc.identifier.endpage684
dc.contributor.firstauthorID176182


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record